Numerus – Company Profile
Numerus specialises in clinical statistics, Health Technology Assessment (EU HTA) and Real-World Evidence (RWE). We provide support to pharmaceutical and biotech companies worldwide in the planning, analysis and evaluation of clinical studies, as well as in strategic decision-making for regulatory approval, reimbursement and market access. Our core services include statistical consultancy, preparation of Statistical Analysis Plans (SAPs), HTA and AMNOG dossiers, RWE analyses, epidemiology, and strategic data analyses. Numerus delivers accurate, practical solutions that help streamline research and support informed decision-making.